FDA approves Abbott’s latest drug-eluting stent

FDA approves Abbott’s latest drug-eluting stent

Source: 
Drug Delivery Business News
snippet: 

Abbott (NYSE:ABT) said today that it won FDA approval for its Xience Sierra everolimus-eluting coronary stent. The company’s device features a thin profile, improved flexibility and longer lengths than previous stents. The device and delivery system were designed to help clinicians tackle complex cases, like those involving multiple or totally blocked vessels, according to Abbott.